Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Privatdozent/in, Zentrum für Chirurgie
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comparison of three cellular assays to predict the course of CMV infection in liver transplant recipientsIn: Vaccines Jg. 9 (2021) Nr. 2, S. 88Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in GermanyIn: Deutsches Ärzteblatt international Jg. 118 (2021) Nr. 46, S. 797 - 798Online Volltext: dx.doi.org/ (Open Access)
-
Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplantIn: Transplant Infectious Disease Jg. 23 (2021) Nr. 3, e13553Online Volltext: dx.doi.org/ (Open Access)
-
Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver TransplantationIn: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 1, 124Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Safety and efficacy of tenofovir alafenamide in liver transplant recipients : A single center experienceIn: Transplant Infectious Disease Jg. 23 (2021) Nr. 3, S. e13522Online Volltext: dx.doi.org/ (Open Access)
-
Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in GermanyIn: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 11, 3570Online Volltext: dx.doi.org/ (Open Access)
-
Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy : Results from the German Hepatitis C-RegistryIn: Journal of Viral Hepatitis Jg. 27 (2020) Nr. 7, S. 690 - 698Online Volltext: dx.doi.org/
-
HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity levelIn: BMC Gastroenterology Jg. 20 (2020) Nr. 1, S. 288Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
An mTor-based immunosuppression reduces the antiviral efficacy of NS3/4A and NS5A inhibitors for HCV genotype 1b treatment in vitroIn: Journal of Hepatology Jg. 70 (2019) Nr. 1 Suppl., S. e829Online Volltext: dx.doi.org/
-
Application of an extended-release tacrolimus formulation allows dose reduction and stabilizes graft function after liver transplantationIn: Journal of Hepatology Jg. 70 (2019) Nr. 1 Suppl., S. e557 - e558Online Volltext: dx.doi.org/
-
Efficacy of IgM-enriched Immunoglobulin for Vasopressor-resistant Vasoplegic Shock After Liver TransplantationIn: Transplantation Jg. 103 (2019) Nr. 2, S. 381 - 386Online Volltext: dx.doi.org/ (Open Access)
-
Improving the vaccination status of liver transplant patients : Effectiveness of personally addressing patients and written recommendations to family physicians after 3 yearsIn: Transplant Infectious Disease Jg. 21 (2019) Nr. 5, S. e13140Online Volltext: dx.doi.org/ (Open Access)
-
KDIGO-Leitlinie zu Prävention, Diagnostik, Evaluation und Therapie der Hepatitis-C-Virus-Infektion bei chronischer Nierenerkrankung : Deutsche Übersetzung und KurzfassungIn: Der Nephrologe Jg. 14 (2019) Nr. 1, S. 46 - 50Online Volltext: dx.doi.org/
-
Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic miceIn: Cancer Medicine Jg. 8 (2019) Nr. 8, S. 3793 - 3802Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant RecipientsIn: Transplantation Proceedings Jg. 51 (2019) Nr. 6, S. 1962 - 1971Online Volltext: dx.doi.org/
-
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipientsIn: Transplant Infectious Disease Jg. 21 (2019) Nr. 5, S. e13146Online Volltext: dx.doi.org/ (Open Access)
-
The Effect of Immunosuppression on Coagulation After Liver TransplantationIn: Liver Transplantation Jg. 25 (2019) Nr. 7, S. 1054 - 1065Online Volltext: dx.doi.org/
-
Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function.In: Transplantation Direct Jg. 5 (2019) Nr. 1, S. e419Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Verwendung HBV- oder HCV-infizierter Spenderorgane bei der Leber- und NierentransplantationIn: Der Gastroenterologe Jg. 14 (2019) Nr. 4, S. 260 - 268Online Volltext: dx.doi.org/
-
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyIn: Journal of Hepatology Jg. 69 (2018) Nr. 4, S. 982 - 984Online Volltext: dx.doi.org/ (Open Access)
-
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin ProphylaxisIn: Annals of Transplantation Jg. 23 (2018) S. 789 - 801Online Volltext: dx.doi.org/ (Open Access)
-
The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotypeIn: Transplant Infectious Disease Jg. 20 (2018) Nr. 1, S. e12803Online Volltext: dx.doi.org/
-
Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to Five Transplant Recipients : Early Treatment with Direct Acting Antivirals Successfully Prevents HCV-InfectionIn: Transplant International Jg. 30 (2017) Nr. Suppl. 4 SI, S. 28 Abstract P02Online Volltext: dx.doi.org/
-
Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to five Transplant Recipients : Early treatment with direct acting Antivrials successfully Prevents Chronic HCV InfectionIn: Transplant International Jg. 30 (2017) Nr. Suppl. 2 SI, S. 37 - 38 Abstract OS092Online Volltext: dx.doi.org/
-
CMV elispot assays are superior to the quantiferon CMV assay to predict protection from CMV reactivation in kidney ans liver transplant recipientsIn: HLA: Immune Response Genetics (Human Leukocyte Antigens) Jg. 89 (2017) Nr. 6, S. 375Online Volltext: dx.doi.org/
-
Effectiveness of subcutaneous & intravenous Hepatitis B immunoglobulin to prevent reinfection after liver transplantation : Long-term results from an international multicenter non-interventional studyIn: Transplant International Jg. 30 (2017) Nr. S2, Special Issue: Abstracts of the 18th Congress of the European Society for Organ Transplantation, 24‐27 September 2017, Barcelona, Spain, S. 40Online Volltext: dx.doi.org/
-
Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In VivoIn: Transplantation Proceedings Jg. 49 (2017) Nr. 8, S. 1947 - 1955Online Volltext: dx.doi.org/
-
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation : The Phase II SATURN studyIn: Transplant Infectious Disease Jg. 19 (2017) Nr. 3, S. e12696Online Volltext: dx.doi.org/
-
Expression of fibrogenic markers in tumor and tumor-surrounding tissue at time of transplantation correlates with recurrence of hepatocellular carcinoma in patients undergoing liver transplantationIn: Annals of Transplantation Jg. 22 (2017) S. 446 - 454Online Volltext: dx.doi.org/ (Open Access)
-
Feasibility of Elabasvir/Grazoprevir for Trearment of Chronic Hepatitis C Virus Infection in Renal Transplant Recipients with Impaired Allograft FunctionIn: Transplant International Jg. 30 (2017) Nr. Suppl 4 SI, S. 28 Abstract P01Online Volltext: dx.doi.org/
-
How do MTOR Inhibitors modulate HCV replication activity : an approach by whole genome analysisIn: Transplant International Jg. 30 (2017) Nr. S4, Special Issue: Abstracts of the 26th Annual Meeting of the German Transplantation Society, Bonn, Germany, 25–28 October 2017, S. 38Online Volltext: dx.doi.org/
-
Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplantIn: Clinical Transplantation Jg. 31 (2017) Nr. 6, S. e12974Online Volltext: dx.doi.org/
-
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyIn: Hepatology Jg. 66 (2017) Nr. S1, Special Issue: The 68th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2017, S. 877AOnline Volltext: dx.doi.org/
-
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyIn: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 18 - 18
-
Impact of donor specific antibodies following liver transplantationIn: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 14 - 14Online Volltext: dx.doi.org/
-
Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics : A re-examination of the situationIn: Minerva Gastroenterologica e Dietologica Jg. 63 (2017) Nr. 1, S. 55 - 61Online Volltext: dx.doi.org/
-
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseIn: Transplant International Jg. 30 (2017) Nr. 3, S. 243 - 255Online Volltext: dx.doi.org/ (Open Access)
-
Sofosbuvir impairs proliferation of hepatocytes in vitro and in vivoIn: Transplant International Jg. 30 (2017) Nr. Suppl. 4, S. 17 - 17
-
Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipientsIn: Transplantation Jg. 101 (2017) Nr. 5, S. 980 - 986Online Volltext: dx.doi.org/
-
Transplanting HCV-infected kidneys into uninfected recipientsIn: The New England Journal of Medicine Jg. 377 (2017) Nr. 11, S. 1103 - 1104Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progressionIn: Cancer Medicine Jg. 5 (2016) Nr. 10, S. 2942 - 2952Online Volltext: dx.doi.org/ (Open Access)
-
Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis : A retrospective multicenter analysisIn: Liver Transplantation Jg. 22 (2016) Nr. 1, S. 42 - 52Online Volltext: dx.doi.org/ (Open Access)
-
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionIn: Liver Transplantation Jg. 22 (2016) Nr. 4, S. 446 - 458Online Volltext: dx.doi.org/ (Open Access)
-
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohortIn: Gut Jg. 65 (2016) Nr. 11, S. 1861 - 1870Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostics and treatment of a severe humoral rejection after liver transplantation : donor-specific antibodies as a still underestimated cause of graft failureIn: Zeitschrift für Gastroenterologie Jg. 54 (2016) Nr. 7, S. 647 - 652Online Volltext: dx.doi.org/
-
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis CIn: Annals of Hepatology Jg. 15 (2016) Nr. 4, S. 512 - 523
-
Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach TransplantationIn: Zeitschrift für Gastroenterologie Jg. 54 (2016) Nr. 7, S. 665 - 684Online Volltext: dx.doi.org/
-
Hepatitis C und NierenerkrankungenIn: Der Nephrologe Jg. 11 (2016) Nr. 5, S. 361 - 374Online Volltext: dx.doi.org/
-
Modernes Management und neue Herausforderungen bei FettlebererkrankungenIn: Klinikarzt Jg. 45 (2016) Nr. 12, S. 596 - 601Online Volltext: dx.doi.org/
-
Selection and use of immunosuppressive therapies after liver transplantation : current German practiceIn: Clinical Transplantation Jg. 30 (2016) Nr. 5, S. 487 - 501Online Volltext: dx.doi.org/
-
Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population SampleIn: Annals of Transplantation Jg. 21 (2016) S. 200 - 207Online Volltext: dx.doi.org/
-
When and How to Treat HCV Infection with the New Antivirals before or after Liver TransplantationIn: Visceral Medicine Jg. 32 (2016) Nr. 4, S. 258 - 262Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allograftsIn: Liver International Jg. 35 (2015) Nr. 3, S. 905 - 913Online Volltext: dx.doi.org/
-
A GATA-1 binding site mutation leads to reduced TRAIL expression in human HCCIn: Journal of Viral Hepatitis Jg. 22 (2015) Nr. S2, S. 131Online Volltext: dx.doi.org/
-
Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence : Interim results of a multicenter compassionate use programIn: Hepatology Jg. 62 (2015) Nr. S1, S. 341AOnline Volltext: dx.doi.org/
-
Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : interim results of a compassionate use programIn: Journal of Viral Hepatitis Jg. 22 (2015) Nr. Suppl. 3, S. 4 - 5Online Volltext: dx.doi.org/
-
Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : Interim results of a multicenter compassionate use programIn: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. 619 - S620Online Volltext: dx.doi.org/
-
Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV in patients coinfected with HIV : Interim results of a multicenter compassionate use programIn: Hepatology Jg. 62 (2015) Nr. Suppl. 1, S. 728A - 729AOnline Volltext: dx.doi.org/
-
Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver TransplantIn: Digestion Jg. 91 (2015) Nr. 4, S. 326 - 333Online Volltext: dx.doi.org/
-
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplantIn: Transplantation Jg. 99 (2015) Nr. 4, S. 841 - 847Online Volltext: dx.doi.org/ (Open Access)
-
Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantationIn: Human Immunology Jg. 76 (2015) Nr. 9, S. 631 - 635Online Volltext: dx.doi.org/
-
Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver TransplantationIn: Digestion Jg. 91 (2015) Nr. 2, S. 117 - 127Online Volltext: dx.doi.org/
-
HCV replication activity is modified by mTor-inhibitors in vitro which is mediated by PMLIn: Journal of Viral Hepatitis Jg. 22 (2015) Nr. Suppl. 2, S. 69 - 70Online Volltext: dx.doi.org/
-
Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agentsIn: World Journal of Hepatology Jg. 7 (2015) Nr. 3, S. 532 - 538Online Volltext: dx.doi.org/
-
Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplantIn: World Journal of Hepatology Jg. 7 (2015) Nr. 9, S. 1287 - 1296Online Volltext: dx.doi.org/
-
On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT) : Interim data from the phase II saturn studyIn: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. S 191 - S192Online Volltext: dx.doi.org/
-
Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection : Interim results of a multicenter European compassionate use programIn: Hepatology Jg. 62 (2015) Nr. S1, S. 225A - 226AOnline Volltext: dx.doi.org/
-
TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survivalIn: International Journal of Cancer Jg. 136 (2015) Nr. 4, S. E154 - E160Online Volltext: dx.doi.org/ (Open Access)
-
The tumor suppressor PML mediates everolimus- induced changes of the HCV replication activityIn: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. 582Online Volltext: dx.doi.org/
-
Therapie der Hepatitis C bei Patienten mit Zirrhose sowie vor und nach LebertransplantationIn: Der Gastroenterologe Jg. 10 (2015) Nr. 4, S. 297 - 304Online Volltext: dx.doi.org/
-
Hepatitis C-associated liver carcinogenesis : Role of PML nuclear bodiesIn: World Journal of Gastroenterology Jg. 20 (2014) Nr. 35, S. 12367 - 12371Online Volltext: dx.doi.org/ (Open Access)
-
Laboratory monitoring after liver transplantationIn: Der Gastroenterologe Jg. 9 (2014) Nr. 2, S. 112 - 116Online Volltext: dx.doi.org/
-
Mini-laparoscopy is superior in detecting liver cirrhosis and metastases in liver cancer : an over 10-year experience in 1,788 casesIn: Digestion Jg. 89 (2014) Nr. 2, S. 156 - 164Online Volltext: dx.doi.org/
-
Retransplantation for Hepatitis C Recurrence : Should We Do It?In: American Journal of Transplantation Jg. 14 (2014) Nr. Suppl. 3, S. 705Online Volltext: dx.doi.org/
-
Biliary strictures and recurrent disease after liver transplantation for primary sclerosing cholangitis - a large, multicenter cohort analysis with long-term follow-upIn: Journal of Hepatology Jg. 58 (2013) Nr. Suppl. 1, S. S42 - S43Online Volltext: dx.doi.org/
-
Daily low-dose Tacrolimus (TAC) is a save and efficient immunosuppressive regimen during triple drug therapy post liver transplantIn: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 32 - 33
-
Daily low-dose tacrolimus (TAC) is a safe and efficient immunosuppressive regimen during HCV triple drug therapy post liver transplant - A 24 weeks interim analysisIn: Transplant International Jg. 26 (2013) Nr. Suppl. 1, S. 6
-
Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinomaIn: Digestion Jg. 87 (2013) Nr. 3, S. 176 - 181Online Volltext: dx.doi.org/
-
Extrahepatic malignancies after liver transplantation for primary sclerosing cholangitis - a long-term follow-up observational study of a large, multicenter cohortIn: Journal of Hepatology Jg. 58 (2013) Nr. Suppl. 1, S. S395Online Volltext: dx.doi.org/
-
HCV-Reinfektion nach Lebertransplantation : Management und erste Ergebnisse mit der Telaprevir-basierten Triple-TherapieIn: Deutsche Medizinische Wochenschrift: DMW Jg. 138 (2013) Nr. 36, S. 1759 - 1764Online Volltext: dx.doi.org/
-
Lebertransplantation - Wo stehen wir heute?In: Deutsche Medizinische Wochenschrift - DMW Jg. 138 (2013) Nr. 28-29, S. 1471 - 1477Online Volltext: dx.doi.org/
-
Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancyIn: Liver Transplantation Jg. 19 (2013) Nr. 12, S. 1411 - 1412Online Volltext: dx.doi.org/
-
Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in MiceIn: PLoS ONE Jg. 7 (2012) Nr. 9, S. e44474Online Volltext: dx.doi.org/ (Open Access)
-
Locoregional therapy for hepatocellular carcinoma : Radioembolization with yttrium-90 microspheresIn: Minerva Gastroenterologica e Dietologica Jg. 57 (2011) Nr. 3, S. 287 - 298
-
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosisIn: International Journal of Cancer Jg. 128 (2011) Nr. 10, S. 2436 - 2443Online Volltext: dx.doi.org/
-
Onset of heart failure determines the hepatic cell death patternIn: Annals of Hepatology Jg. 10 (2011) Nr. 2, S. 174 - 179Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver InjuryIn: Digestion Jg. 84 (2011) Nr. 1, S. 54 - 59Online Volltext: dx.doi.org/
-
Die Interaktion zwischen Leber und HerzIn: Zeitschrift für Herz-, Thorax- und Gefässchirurgie Jg. 24 (2010) Nr. 6, S. 334 - 340Online Volltext: dx.doi.org/
-
Pulmonale Affektion bei fortgeschrittener Lebererkrankung – hepatopulmonales Syndrom und portopulmonale HypertonieIn: Medizinische Klinik Jg. 105 (2010) Nr. 12, S. 916 - 923Online Volltext: dx.doi.org/
-
Does ursodeoxycholic acid exert a protective effect on liver grafts in orthotopic liver transplantation?In: Digestion Jg. 86 (2012) Nr. 3, S. 206 - 207Online Volltext: dx.doi.org/
-
MTOR polymorphisms and de novo diabetes mellitus in liver transplantation patients treated with everolimus
87th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) ; 1 March – 3 March 2021, Digital,In: Naunyn-Schmiedeberg's Archives of Pharmacology Jg. 394 (2021) Nr. Suppl. 1, S. S25Online Volltext: dx.doi.org/ (Open Access) -
CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2aIn: Journal of Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 136Online Volltext: dx.doi.org/
-
Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R)In: Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 424AOnline Volltext: dx.doi.org/
-
Successful early treatment of HCV viremia after transplantation of HCV positive renal allografts into HCV negative recipients
27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,In: Transplant International Jg. 31 (2018) Nr. Suppl. 5, S. 11 -
The effect of immunosuppression on coagulation in patients after liver transplantationIn: Journal of Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 386 - S387Online Volltext: dx.doi.org/
-
Treatment with Grazoprevir/Elbasvir for renal transplant recipients with chronic Hepatitis C Virus Infection and impaired allograft functionIn: Nephrology Dialysis Transplantation (NDT) Jg. 33 (2018) Nr. Suppl_1, S. i602 - i603Online Volltext: dx.doi.org/ (Open Access)
-
Daclatasvir plus Sofosbuvir +/- Ribavirin in Liver Transplant Recipients with HCV Recurrence : Interim Results of a European Multicenter Compassionate Use ProgramIn: Transplantation Jg. 100 (2016) Nr. Suppl. 5, S. 181Online Volltext: dx.doi.org/
-
Donor specific antibodies post liver transplant : Predictors and protectorsIn: Journal of Hepatology Jg. 64 (2016) Nr. 2, Suppl., S. S544Online Volltext: dx.doi.org/
-
Predictors and protectors of donor specific antibodies after liver transplantationIn: Transplant International Jg. 29 (2016) Nr. Suppl. 3, S. 22Online Volltext: dx.doi.org/
-
Predictors for the Development of Donor Specific Antibodies After Liver TransplantationIn: Transplantation Jg. 100 (2016) Nr. Suppl. 5, S. 238Online Volltext: dx.doi.org/
-
Successful therapy of chronic hepatitis C virus infectionwith sofosbuvir and ledipasvir in renal transplant recipientsIn: Transplant International Jg. 29 (2016) Nr. Suppl. 3, S. 20 - 21Online Volltext: dx.doi.org/
-
Impfstatus von Patienten nach Lebertransplantation – Eine Querschnittsstudie
121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 64Online Volltext: dx.doi.org/ -
Safety and efficacy of daclatasvir plus sofosbuvir with or without ribarivin for hepatitis C post-transplant : interim results from the compassionate use program
24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,In: Transplant International Jg. 28 (2015) Nr. Suppl. 2, S. 35Online Volltext: dx.doi.org/ -
Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patientsIn: Hepatology Jg. 60 (2014) Nr. Suppl. 1, S. 697AOnline Volltext: dx.doi.org/ (Open Access)
-
Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patients
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International Jg. 27 (2014) Nr. Suppl. 3, S. 19Online Volltext: dx.doi.org/ -
Reinfection prophylaxis with entecavir monotherapy is successful and safe in patients with hepatitis B virus infection after liver transplantationIn: Hepatology Jg. 60 (2014) Nr. Suppl. 1, S. 538AOnline Volltext: dx.doi.org/
-
The influence of mTor-Inhibitors on HCV replication after liver transplantationIn: Hepatology Jg. 60 (2014) Nr. Suppl. 1, Special Issue: The 65th Annual Meeting of the American Association for the Study of Liver Diseases, S. 533AOnline Volltext: dx.doi.org/